Puma Biotechnology, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2017
Total Assets: $165.5M
Liabilities Breakdown FY2017
Total Liabilities: $112.2M
Asset Breakdown
Total Assets: $165.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $81.7M | 49.4% |
| Accounts Receivable | $9.7M | 5.8% |
| Inventory | $2.0M | 1.2% |
| Property, Plant & Equipment | $4.5M | 2.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $48.4M | 29.2% |
| Other Assets | $19.3M | 11.7% |
Liabilities Breakdown
Total Liabilities: $112.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $27.7M | 24.7% |
| Long-Term Debt | $48.5M | 43.2% |
| Other Liabilities | $36.1M | 32.1% |